Domain Not Resolving

Google Font API

DNSSEC

LetsEncrypt

nginx

Cloudflare CDN

IPv6

Cloudflare Hosting

Cloudflare

Google Analytics 4

Process Owner

Arturo Reyes

Business Management

Brian Savage

Group EVP, Chief Legal Officer

David Stark

Executive Vice President Global R&D and Chief Medical Officer

Eric Hughes

Executive Vice President, Chief Human Resources Officer and Corporate Affairs

Galia Inbar

Hafrun Fridriksdottir

Legal

Joseph Crystal

SVP and General Counsel, North America and Global Operations

Kirsten Bauer

Senior Vice President, General Counsel-Global Litigation

Norv P. McAndrew

Business Process Owner Serialization

Sabrina Schmid

Yitzhak Peterburg

Jean Halfon

Catherine Pearce

Sol Barer

Ory Slonim

Joseph Nitzani

Itzhak Krinsky

Rosemary Crane

Rob Koremans

President and CEO, Global Specialty Medicines

Mark Sabag

EVP international markets

Eric A. Hughes

Executive Vice President, Global R&D and Chief Medical Officer

Valgeir Petursson

Sr. Director Logistics Europe & PTC/PP

Guilherme Safioti

Global Medical Director, Connected Respiratory

Stephan Gotthardt

Senior Vice President Europe Supply Chain

Gabriela Ridner Bahar

Principal Scientist

Dipankar Bhattacharjee

President & CEO: Generics Europe

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Heptares Therapeutics develops novel, small-molecule drugs for G-protein-coupled receptors (GPCRs).

BioLineRx is a late clinical-stage biopharmaceutical development company that focuses on oncology.

Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases.

Microchips Biotech, Inc. is dedicated to improving the lives of patients by revolutionizing drug delivery.

Ignyta is a biotechnology company catalyzing personalized medicine in autoimmune diseases.

TransPharma Medical is a specialty pharmaceutical company focused on the development and commercialization of drug-products.

Cocrystal Discovery is a biotechnology company developing antiviral therapeutics for human diseases.

Middle East Companies With More Than 10 Employees (Top 10K)

Biopharma Companies

Middle East Health Care Companies

Medical Public Companies With More Than $500 in Revenue

Teva Pharmaceuticals is a pharmaceutical company specializing in the development, production, and marketing of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients.

Royalty Pharma

Post-IPO Equity - Teva Pharmaceuticals

Post-IPO Debt - Teva Pharmaceuticals

Berkshire Hathaway

Tel Aviv

Israel

Asia

Teva Pharmaceuticals

U.S. Somatostatin Analogs Market to Hit USD 4.78 Billion by 2032, at a CAGR 7.5% | VMR

Europe Somatostatin Analogs Market Size to be Worth USD 4.29 Billion by 2032, with a Projected CAGR of 7.7%

Teva and Immunai partner to improve clinical decision making

Teva Pharmaceutical Flashes A Buy Signal On Upbeat Third-Quarter Report

Global Anorexiant Market Expected to Reach USD 1,883 Mill...

2024 Research: Pediatric Drugs Market Poised for Robust Growth, Projected at 4.79% CAGR Through 2030

Teva fined €462.6M by European regulators over Copaxone patent and competition allegations

Teva Pharmaceuticals to Pay $450 Million to Settle Kickback Allegations

Baltimore reaches $80M settlement with Teva Pharmaceuticals in opioid case

Teva Pharmaceuticals’ Patent Dispute

Teva Pharmaceuticals is a major producer of generic medicines, providing a wide range of affordable pharmaceutical products to treat various health conditions.

Teva develops innovative medicines, focusing on new treatments for complex diseases, including neurological and respiratory conditions.

Teva is involved in the development of complex generics, which are advanced formulations of generic drugs that offer alternative dosing options and delivery methods.

Teva produces biosimilars, which are biologic medical products highly similar to already approved reference products, offering more treatment options.

Teva engages in collaborative research with partners to develop new therapies, particularly in areas like schizophrenia, inflammatory bowel disease, and rheumatoid arthritis.

Teva is part of AION Labs, using AI and big data to accelerate drug discovery and development processes.

United States

North America

India

Puerto Rico

Germany

Europe

HTML5

Microsoft Outlook

Google Analytics

Google Drive

Modernizr

Google Fonts

Bootstrap

.NET 4.5

GlobalSign

Vimeo

Teva Pharmaceuticals owns Teva India

Teva Pharmaceuticals owns Teva Canada

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

news impact assignment basic	general	Mar 8, 2024 2:20 PM	9e085a60
public peers	general
news daily refresh	general	Dec 4, 2024 2:16 PM	0ba45926
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 2:20 PM	675a5095
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	ada7ad9c
crunchbase profile	general	Nov 25, 2024 11:39 AM	f68449f2
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 2:15 PM	4f8b5cfe
peers	general
news basic	general	Dec 4, 2024 2:13 PM	b396d8ec
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:TEVAPHARM

Teva Pharmaceutical Industries Ltd.

Last Close

17.08

22/11 21:00

Market Cap

19.23B

Beta: -

Volume Today

6.01M

Avg: -